"The disciplinary committee is making scathing criticism of the company," says Sverre Linton, the association's lawyer Sverre Linton, who himself has been critical of Aegirbio's disclosure of information.
Aegirbio became a small saver favorite in 2021 after news of giant sales of covid tests to Asia. But the course crashed after SVT revealed links between Aegirbio's partner companies and actors in Sweden's largest fraud scandal, the mobile ravages.
In the year that followed, Aegirbio backed away from all pledges of upcoming multimillion-dollar revenue and referred all errors to Nowmed.
But SVT's review has also shown that Aegirbio has repeatedly delayed telling about bad news. A company linked to Aegirbio's current CEO managed to earn millions of dollars by selling Aegirbio shares on time, while thousands of small savers made huge losses.
One of these, Ronny Jansson, notified Aegirbio to Nasdaq last year.
Javascript is turned off
Javascript must be turned on to play video
Learn more about browser support
Ronny Jansson is one of many who lost hundreds of thousands of kronor when the medtech company Aegirbio crashed on the stock exchange. "All of a sudden, my savings were up to 1.6 million. It was a blast. Then when you realize that it's based on scam orders, it feels less good. Photo: Tomas Hallstan/SVT
Nasdaq, in turn, reported Aegirbio to the Exchange's disciplinary committee in December with a request that the company be delisted. But the disciplinary board is content with an injunction, which Aegirbios chief executive Bradley Messmer describes in a written comment as "the right decision":
"The company hereby puts a very turbulent period behind it and looks forward to being able to focus on its business operations."
"The company receives hefty fines, but there are probably many who are surprised that it did not get even higher or delisting. Many are now probably asking themselves what it really takes to be delisted, says Sverre Linton of the Swedish Shareholders' Association.
Following the disciplinary board's decision, Aegirbio's share rose by over 100 percent on Tuesday, only to fall on Wednesday.
Javascript is turned off
Javascript must be turned on to play video
Learn more about browser support
After SVT's disclosure, the stock fell sharply. Hear the tours about the companies around the stock market rocket Aegirbio that was linked to the so-called mobile tangle.
Javascript is turned off
Javascript must be turned on to play video
Learn more about browser support
Ronny Jansson is one of many who lost hundreds of thousands of kronor when the medtech company Aegirbio crashed on the stock exchange. "All of a sudden, my savings were up to 1.6 million. It was a blast. Then when you realize that it's based on scam orders, it feels less good. Photo: Tomas Hallstan/SVT